The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

BioNTech and the UK government's alliance to bring personalized cancer immunotherapy to patients is making progress, but the National Health Service has to show it can deliver on clinical trials recruitment.